Reata Pharmaceuticals Inc (NASDAQ:RETA)

Delayed Data
As of 4:00pm ET
 -2.34 / -8.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 75.00 and a low estimate of 35.00. The median estimate represents a +78.50% increase from the last price of 24.09.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.83%
Growthannually -10.09%


Growthquarterly -77.99%
Growthannually 35.44%
Key to the earnings and sales forecast charts.